{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:36:46Z","timestamp":1792420606962,"version":"4.5.0"},"reference-count":70,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:sec id=\"ab-srv230005-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Most ovarian cancers originate in the fimbriated end of the fallopian tube. This has led to the hypothesis that surgical resection of the fallopian tubes at the time of gynecologic and nongynecologic surgical procedures\u2014referred to as an opportunistic salpingectomy\u2014may prevent the development of epithelial ovarian cancer for women at an average risk of developing the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv230005-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compile a comprehensive, state-of-the-science review examining the current landscape of performing bilateral salpingectomy for ovarian cancer prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv230005-6\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>A systematic review of the literature was performed on March 4, 2022, to identify studies examining salpingectomy for ovarian cancer prevention. This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 statement. Four databases were selected: PubMed via the National Library of Medicine\u2019s PubMed.gov, Embase via Elsevier\u2019s Embase.com, Cochrane Central Register of Controlled Trials (CENTRAL) via Wiley\u2019s Cochrane Library, and Northern Light Life Sciences Conference Abstracts via Ovid. A total of 20 gray literature sources, including 1 database, 2 registers, 1 repository, 1 index, 1 archive, 1 preprint server, 1 agency, and 12 organizations, were also searched.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv230005-7\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>The initial search produced 1089 results; a total of 158 publications were included in the final review. Salpingectomy has been associated with ovarian cancer risk reduction of approximately 80%. Studies have demonstrated that salpingectomy was safe, cost-effective, and was not associated with an earlier age of menopause onset. With widespread implementation, salpingectomy has the potential to reduce ovarian cancer mortality in the US by an estimated 15%. Both physician and patient awareness regarding the adnexa as the origin for most ovarian cancers, as well as the existence of salpingectomy and its potential benefits in reducing ovarian cancer risk, has increased during the past decade. Raising awareness and developing effective implementation strategies are essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-srv230005-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The results of this systematic review suggest that bilateral salpingectomy for ovarian cancer prevention was safe and feasible and has the potential to be a cost-effective and cost-saving strategy across the population. Prospective studies to demonstrate long-term survival outcomes and feasibility in nongynecologic surgical procedures are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2023.4164","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:02:48Z","timestamp":1693998168000},"page":"1204","source":"Crossref","is-referenced-by-count":71,"title":["Salpingectomy for the Primary Prevention of Ovarian Cancer"],"prefix":"10.1001","volume":"158","author":[{"given":"Ryan M.","family":"Kahn","sequence":"first","affiliation":[{"name":"Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Gordhandas","sequence":"additional","affiliation":[{"name":"Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Godwin","sequence":"additional","affiliation":[{"name":"Medical Library, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Michael J.","family":"Worley","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara C.","family":"Long Roche","sequence":"additional","affiliation":[{"name":"Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"srv230005r3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship.","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"srv230005r4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"71","key":"srv230005r5","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"srv230005r6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement.","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"srv230005r8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer.","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"9284","key":"srv230005r9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(01)05992-X","article-title":"Tubal ligation and risk of ovarian cancer.","volume":"358","author":"Piek","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"srv230005r10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis.","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"srv230005r11","doi-asserted-by":"publisher","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"srv230005r12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube.","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"issue":"7","key":"srv230005r13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm.","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"issue":"5","key":"srv230005r14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application.","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"srv230005r15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas.","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"srv230005r16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"srv230005r17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1940-6207.CAPR-14-0293","article-title":"Salpingectomy as a means to reduce ovarian cancer risk.","volume":"8","author":"Daly","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"srv230005r18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jmig.2017.02.014","article-title":"The effect of salpingectomy on ovarian function.","volume":"24","author":"Kotlyar","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"srv230005r19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jmig.2016.08.833","article-title":"3 to 5 Years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function.","volume":"24","author":"Venturella","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"srv230005r20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2022.01.006","article-title":"STop OVarian CAncer (STOPOVCA) young: protocol for a multicenter follow-up study to determine the long-term effects of opportunistic salpingectomy on age at menopause.","volume":"159","author":"Gelderblom","year":"2022","journal-title":"Maturitas"},{"issue":"2","key":"srv230005r21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/1471-0528.14182","article-title":"Impact of opportunistic salpingectomy on anti\u2013M\u00fcllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial.","volume":"124","author":"Song","year":"2017","journal-title":"BJOG"},{"issue":"5","key":"srv230005r22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/bjs.11419","article-title":"Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy.","volume":"107","author":"Tomasch","year":"2020","journal-title":"Br J Surg"},{"issue":"4","key":"srv230005r23","doi-asserted-by":"publisher","first-page":"472.e1","DOI":"10.1016\/j.ajog.2017.04.028","article-title":"Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial.","volume":"217","author":"Ganer Herman","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"srv230005r24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4103\/0973-1482.193114","article-title":"Comparing surgical outcome and ovarian reserve after laparoscopic hysterectomy between two methods of with and without prophylactic bilateral salpingectomy: a randomized controlled trial.","volume":"14","author":"Asgari","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"srv230005r25","doi-asserted-by":"publisher","first-page":"221.e1","DOI":"10.1016\/j.ajog.2020.02.005","article-title":"Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.","volume":"223","author":"Hanley","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"srv230005r26","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1097\/AOG.0000000000003164","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"srv230005r28","doi-asserted-by":"publisher","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"srv230005r29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1158\/1940-6207.CAPR-21-0121","article-title":"Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States.","volume":"14","author":"Karia","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"srv230005r30","doi-asserted-by":"publisher","first-page":"721.e1","DOI":"10.1016\/j.ajog.2020.04.028","article-title":"The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"srv230005r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention.","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"srv230005r32","doi-asserted-by":"publisher","first-page":"713.e1","DOI":"10.1016\/j.ajog.2015.04.031","article-title":"National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.","volume":"213","author":"Mikhail","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"srv230005r33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis.","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"srv230005r34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere.","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"5","key":"srv230005r35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00432-014-1622-6","article-title":"Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.","volume":"140","author":"Vorwergk","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"srv230005r36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jmig.2016.12.004","article-title":"Operative outcomes of opportunistic bilateral salpingectomy at the time of benign hysterectomy in low-risk premenopausal women: a systematic review.","volume":"24","author":"Kho","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"srv230005r37","doi-asserted-by":"publisher","first-page":"172.e1","DOI":"10.1016\/j.ajog.2018.05.019","article-title":"Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.","volume":"219","author":"Hanley","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"srv230005r39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3747\/co.20.1471","article-title":"Salpingectomy to prevent ovarian cancer: a countercurrents series.","volume":"20","author":"Narod","year":"2013","journal-title":"Curr Oncol"},{"issue":"3","key":"srv230005r40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3747\/co.20.1548","article-title":"Fallopian tube removal: \u201cSTIC-ing\u201d it to ovarian cancer: what is the utility of prophylactic tubal removal?","volume":"20","author":"Herzog","year":"2013","journal-title":"Curr Oncol"},{"issue":"2","key":"srv230005r41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"srv230005r42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","article-title":"Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.","volume":"146","author":"Dilley","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"srv230005r43","doi-asserted-by":"publisher","first-page":"106.e1","DOI":"10.1016\/j.ajog.2018.08.032","article-title":"Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.","volume":"220","author":"Venkatesh","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"srv230005r44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jogc.2017.06.038","article-title":"The cost-effectiveness of salpingectomies for family planning in the prevention of ovarian cancer.","volume":"40","author":"Tai","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"srv230005r45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2018.11.009","article-title":"The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.","volume":"152","author":"Subramaniam","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"4","key":"srv230005r46","doi-asserted-by":"publisher","first-page":"397.e1","DOI":"10.1016\/j.ajog.2021.03.032","article-title":"The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.","volume":"225","author":"Naumann","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"srv230005r47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.04.005","article-title":"Opportunistic salpingectomy in women undergoing non-gynecologic abdominal surgery.","volume":"158","author":"Cook","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"srv230005r48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/gyn.2021.0047","article-title":"Opportunistic salpingectomy at time of nongynecologic elective procedures could reduce ovarian cancer\u2013related costs and mortality.","volume":"38","author":"Hughes","year":"2022","journal-title":"J Gynecol Surg"},{"key":"srv230005r49","article-title":"Opportunistic salpingectomy at the time of laparoscopic cholecystectomy for ovarian cancer prevention: a cost-effectiveness analysis.","author":"Matsuo","year":"2022","journal-title":"Ann Surg"},{"key":"srv230005r50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100824","article-title":"Physician attitudes and knowledge on prophylactic salpingectomy in perimenopausal patients.","volume":"37","author":"Fialkow","year":"2021","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"srv230005r51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejogrb.2013.06.030","article-title":"Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC).","volume":"170","author":"Kamran","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"srv230005r52","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/ajo.12402","article-title":"Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice.","volume":"55","author":"Kapurubandara","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"srv230005r53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/1471-0528.13741","article-title":"Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: there is lack of clarity on a number of key issues.","volume":"123","author":"Manchanda","year":"2016","journal-title":"BJOG"},{"issue":"7-8","key":"srv230005r54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.gyobfe.2016.05.003","article-title":"Current surgical practice of prophylactic and opportunistic salpingectomy in France.","volume":"44","author":"Chene","year":"2016","journal-title":"Gynecol Obstet Fertil"},{"key":"srv230005r55","doi-asserted-by":"publisher","first-page":"126S","DOI":"10.1097\/01.AOG.0000447088.95480.bc","article-title":"Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization.","volume":"123","author":"Morosky","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"srv230005r56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jmig.2013.02.010","article-title":"Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization.","volume":"20","author":"Gill","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"srv230005r57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/07357907.2016.1242597","article-title":"Physicians\u2019 perspectives and practice patterns toward opportunistic salpingectomy in high- and low-risk women.","volume":"35","author":"Jones","year":"2017","journal-title":"Cancer Invest"},{"issue":"4","key":"srv230005r58","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5468\/ogs.2015.58.4.284","article-title":"Public perception of risk-reducing salpingectomy for preventing ovarian cancer.","volume":"58","author":"Kang","year":"2015","journal-title":"Obstet Gynecol Sci"},{"issue":"1","key":"srv230005r59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12905-020-01065-8","article-title":"Bridging different realities\u2014a qualitative study on patients\u2019 experiences of preoperative care for benign hysterectomy and opportunistic salpingectomy in Sweden.","volume":"20","author":"Collins","year":"2020","journal-title":"BMC Womens Health"},{"issue":"1","key":"srv230005r60","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1186\/s12913-021-06767-9","article-title":"Patients\u2019 and professionals\u2019 perspectives on implementation of opportunistic salpingectomy: a mixed-method study.","volume":"21","author":"Gelderblom","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"srv230005r61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4274\/tjod.galenos.2020.12129","article-title":"Patients\u2019 perceptions toward and the driving factors of decision-making for opportunistic bilateral salpingectomy at the time of cesarean section.","volume":"17","author":"Yassa","year":"2020","journal-title":"Turk J Obstet Gynecol"},{"issue":"9","key":"srv230005r63","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jamasurg.2016.0804","article-title":"Trends in inpatient and outpatient hysterectomy and oophorectomy rates among commercially insured women in the United States, 2000-2014.","volume":"151","author":"Doll","year":"2016","journal-title":"JAMA Surg"},{"issue":"4","key":"srv230005r64","doi-asserted-by":"publisher","first-page":"399.e1","DOI":"10.1016\/j.ajog.2021.06.074","article-title":"Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.","volume":"225","author":"Mandelbaum","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"srv230005r65","doi-asserted-by":"publisher","first-page":"257.e1","DOI":"10.1016\/j.ajog.2022.04.036","article-title":"Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.","volume":"227","author":"Karia","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"srv230005r66","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e53","article-title":"Should national societies recommend opportunistic salpingectomy?","volume":"28","author":"Tamussino","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"12","key":"srv230005r67","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1055\/s-0042-116493","article-title":"Incidental (prophylactic) salpingectomy at benign gynecologic surgery and cesarean section: a survey of practice in Austria.","volume":"76","author":"Potz","year":"2016","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"srv230005r68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00404-015-3697-y","article-title":"Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.","volume":"292","author":"P\u00f6lcher","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"srv230005r69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejogrb.2018.03.043","article-title":"Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: what do national societies advise?","volume":"225","author":"Ntoumanoglou-Schuiki","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"srv230005r1","volume-title":"Cancer Facts & Figures 2022","author":"American Cancer Society","year":"2022"},{"key":"srv230005r62","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Brief 214","year":"2016"},{"key":"srv230005r2","unstructured":"National Cancer Institute;? Surveillance, Epidemiology, and End Results Program. Cancer stat facts: ovarian cancer. Accessed February 24, 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html"},{"key":"srv230005r7","unstructured":"Veritas Health Innovation. Covidence systematic review software. Accessed July 26, 2023. https:\/\/www.covidence.org\/"},{"key":"srv230005r27","unstructured":"Society of Gynecologic Oncology. SGO clinical practice statement: salpingectomy for ovarian cancer prevention. November 1, 2013. Accessed October 25, 2022. https:\/\/www.sgo.org\/resources\/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention"},{"key":"#cr-split#-srv230005r38.1","unstructured":"Papers presented at: 20th International Meeting of the European Society of Gynaecological Oncology. November 4-7, 2017"},{"key":"#cr-split#-srv230005r38.2","unstructured":"Vienna, Austria. Accessed July 26, 2023. https:\/\/ijgc.bmj.com\/content\/27\/Suppl_4\/1"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2809261\/jamasurgery_kahn_2023_rv_230005_1774039340.39338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:00:18Z","timestamp":1774450818000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2809261"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.4164","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}